Craft

Avicanna

Stock Price

$0.2

2024-10-29

Market Capitalization

$23.9 M

2024-10-29

Revenue

$16.8 M

FY, 2023

Avicanna Summary

Company Summary

Overview
Avicanna is a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. It supplies Aureus active pharmaceutical ingredients, Pura Earth derma-cosmetic formulations, RHO Phyto medical products, etc. The company offers solutions for dermacosmetics, medical, and pharmaceutical applications.
Type
Public
Status
Active
Founded
2016
HQ
Toronto, CA | view all locations
Website
http://www.avicanna.com/
Cybersecurity rating
Sectors

Key People

  • Aras Azadian

    Aras Azadian, Chief Executive Officer, Co-Founder, Director

    • Setu Purohit, President & Chief Legal Officer, Director, Co-Founder

      • Dave Sohi, Chief Financial Officer

        • Ivana Maric, Executive Vice President, Marketing

          LocationsView all

          1 location detected

          • Toronto, ON HQ

            Canada

            480 University Ave #1502

          Avicanna Financials

          Summary Financials

          Revenue (Q3, 2024)
          $C6.3M
          Gross profit (Q3, 2024)
          $C3.5M
          Net income (Q3, 2024)
          ($C786.0K)
          Cash (Q3, 2024)
          $C812.0K
          EBIT (Q3, 2024)
          $C41.0K
          Enterprise value
          $23.1M

          Footer menu